Latest Regulatory News

Holista Colltech has agreed to pay US$1.8 million to settle a US judgment enforced by the Supreme Court of Western Australia, resolving a long-running dispute with ProImmune Company LLC. The settlement reflects a significant discount on the original US$2.06 million judgment plus accruing interest and legal fees.

Peninsula Energy has won a Supreme Court ruling validating a contentious nearly 20 million share issuance from February despite prospectus lapses, prompting a request to lift its trading suspension.

Xstate Resources has issued a cleansing prospectus to remove trading restrictions on recently placed shares and associated options, following a $1.69 million capital raise priced at 3.3 cents per share. The offer includes free attaching options to placement participants, brokers, and consultants, subject to shareholder approval.

FirstWave Cloud Technology has landed a two-year, USD250,000 software subscription contract with Mexico’s state-owned development bank Banobras, marking its first major public sector win and debut via Grupo Salinas’ OmniPrinter channel.

Hastings Technology Metals is on track to commission its Kabin Buri Hydromet Plant in Thailand by June 2026, aiming for first production of premium Mixed Rare Earth Chloride flakes by Q4. The plant promises near-term revenue streams and leverages lower operating costs in Thailand's Eastern Economic Corridor.

Patronus Resources has pledged to back Pan African Resources’ A$311 million acquisition of Emmerson Resources, raising committed shareholder support to about 32%. The backing is conditional on the share exchange ratio, absence of superior proposals, and a positive independent expert opinion.

Multistack International is progressing with the sale of its core assets to Willing Y Limited, maintaining operations cautiously while cash reserves decline amid ongoing operating losses.

Manhattan Gold Corporation has secured A$3 million to kick off a 4,000m reverse circulation drilling program at its Hook Lake Project in Nunavut, Canada, while expanding its exploration area by 81km² with new mineral claims covering high-grade gold anomalies.

Alterity Therapeutics has unveiled fresh Phase 2 data revealing ATH434’s ability to slow functional decline in Multiple System Atrophy patients, measured by the novel MuSyCA scale. This reinforces the drug’s disease-modifying potential ahead of pivotal Phase 3 trials.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

Caspin Resources has agreed to sell its entire Mount Squires Project interest to Agrimin Limited, receiving shares, options, performance rights, and a royalty, while concentrating on advancing its high-grade Bygoo Tin Project in New South Wales.

Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.